These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34622351)

  • 61. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
    Jiang T; Zhang XS; Pan F; Lyu SC; Wang J; Huang MX; He Q; Lang R
    Medicine (Baltimore); 2021 Jul; 100(26):e26487. PubMed ID: 34190174
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy.
    Lei JY; Yan LN; Wang WT
    World J Gastroenterol; 2013 Jul; 19(27):4400-8. PubMed ID: 23885153
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation.
    Lee HS; Choi GH; Joo DJ; Kim MS; Choi JS; Kim SI
    Ann Surg Oncol; 2014 Aug; 21(8):2717-24. PubMed ID: 24916744
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Salvage liver transplantation versus curative treatment for patients with recurrent hepatocellular carcinoma: A systematic review and meta-analysis.
    Liu J; Zhang G; Yang L; Yan D; Yu J; Wei S; Li J; Yi P
    Eur J Surg Oncol; 2024 Jul; 50(7):108427. PubMed ID: 38796968
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis.
    Koh PS; Chan AC; Cheung TT; Chok KS; Dai WC; Poon RT; Lo CM
    HPB (Oxford); 2016 Jan; 18(1):72-8. PubMed ID: 26776854
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation.
    Poon RT; Fan ST; Lo CM; Liu CL; Wong J
    Ann Surg; 2002 Mar; 235(3):373-82. PubMed ID: 11882759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
    World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenario.
    Famularo S; Cillo U; Lauterio A; Donadon M; Vitale A; Serenari M; Cipriani F; Fazio F; Giuffrida M; Ardito F; Dominioni T; Garancini M; Lai Q; Nicolini D; Molfino S; Perri P; Pinotti E; Conci S; Ferrari C; Zanello M; Patauner S; Zimmitti G; Germani P; Chiarelli M; Romano M; De Angelis M; La Barba G; Troci A; Ferraro V; Izzo F; Antonucci A; Belli A; Memeo R; Crespi M; Ercolani G; Boccia L; Zanus G; Tarchi P; Hilal MA; Frena A; Jovine E; Griseri G; Ruzzenente A; Zago M; Grazi G; Baiocchi GL; Vivarelli M; Rossi M; Romano F; Maestri M; Giuliante F; Valle RD; Ferrero A; Aldrighetti L; De Carlis L; Cescon M; Torzilli G;
    HPB (Oxford); 2023 Oct; 25(10):1223-1234. PubMed ID: 37357112
    [TBL] [Abstract][Full Text] [Related]  

  • 72. First-line liver resection and salvage liver transplantation are increasing therapeutic strategies for patients with hepatocellular carcinoma and child a cirrhosis.
    Vennarecci G; Ettorre GM; Antonini M; Santoro R; Maritti M; Tacconi G; Spoletini D; Tessitore L; Perracchio L; Visco G; Puoti C; Santoro E
    Transplant Proc; 2007; 39(6):1857-60. PubMed ID: 17692633
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patients with early recurrence of hepatocellular carcinoma have poor prognosis.
    Kobayashi T; Aikata H; Kobayashi T; Ohdan H; Arihiro K; Chayama K
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):279-288. PubMed ID: 28603096
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis.
    Hu Z; Wang W; Li Z; Ye S; Zheng SS
    Liver Transpl; 2012 Nov; 18(11):1316-23. PubMed ID: 22847898
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Liver Resection for Early Hepatocellular Carcinoma: Preoperative Predictors of Non Transplantable Recurrence and Implications for Treatment Allocation.
    Gelli M; Sebagh M; Porcher R; Romanelli E; Vibert E; Sa Cunha A; Castaing D; Rosmorduc O; Samuel D; Adam R; Cherqui D
    Ann Surg; 2020 Nov; 272(5):820-826. PubMed ID: 32833755
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?
    Landman MP; Feurer ID; Pinson CW; Moore DE
    HPB (Oxford); 2011 Nov; 13(11):783-91. PubMed ID: 21999591
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Salvage living donor liver transplantation for hepatocellular carcinoma recurrence after hepatectomy: Quantitative prediction using ADV score.
    Hwang S; Song GW; Ahn CS; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Yoon YI; Lee SG
    J Hepatobiliary Pancreat Sci; 2021 Nov; 28(11):1000-1013. PubMed ID: 33175453
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.
    Piñero F; Marciano S; Anders M; Orozco Ganem F; Zerega A; Cagliani J; Andriani O; de Santibañes E; Gil O; Podestá LG; McCormack L; Gadano A; Silva M
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):421-7. PubMed ID: 26684693
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis.
    Otto G; Heuschen U; Hofmann WJ; Krumm G; Hinz U; Herfarth C
    Ann Surg; 1998 Mar; 227(3):424-32. PubMed ID: 9527066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.